BIO
Bio-Rad Laboratories IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$7.70B
P/E Ratio
47.88
EPS
$6.01
Beta
1.06
52W High
$343.12
52W Low
$211.43
50-Day MA
$274.07
200-Day MA
$292.68
Dividend Yield
—
Profit Margin
6.52%
Forward P/E
32.47
PEG Ratio
1.19
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Fundamentals
| Revenue (TTM) | $2.59B |
| Gross Profit (TTM) | $1.35B |
| EBITDA | $444.80M |
| Operating Margin | 5.76% |
| Return on Equity | 2.50% |
| Return on Assets | 1.79% |
| Revenue/Share (TTM) | $95.80 |
| Book Value | $255.37 |
| Price-to-Book | 1.12 |
| Price-to-Sales (TTM) | 2.97 |
| EV/Revenue | 2.853 |
| EV/EBITDA | 16.80 |
| Quarterly Earnings Growth (YoY) | -83.00% |
| Quarterly Revenue Growth (YoY) | 1.10% |
| Shares Outstanding | $21.70M |
| Float | $20.90M |
| % Insiders | 16.38% |
| % Institutions | 94.40% |
Historical Volatility
HV 10-Day
70.96%
HV 20-Day
61.85%
HV 30-Day
56.41%
HV 60-Day
43.90%
HV Rank
88.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($297.00 target)
4
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026